Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1986; 79(Suppl 12): 38–43.
PMCID: PMC1290126

Current clinical management of hepatic problems in cystic fibrosis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Park RW, Grand RJ. Gastrointestinal manifestations of cystic fibrosis: a review. Gastroenterology. 1981 Dec;81(6):1143–1161. [PubMed]
  • Roy CC, Weber AM, Morin CL, Lepage G, Brisson G, Yousef I, Lasalle R. Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts. J Pediatr Gastroenterol Nutr. 1982;1(4):469–478. [PubMed]
  • Isenberg JN. Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism. Semin Liver Dis. 1982 Nov;2(4):302–313. [PubMed]
  • Oppenheimer EH, Esterly JR. Hepatic changes in young infants with cystic fibrosis: possible relation to focal biliary cirrhosis. J Pediatr. 1975 May;86(5):683–689. [PubMed]
  • Terblanche J. Treatment of esophageal varices by injection sclerotherapy. Adv Surg. 1981;15:257–291. [PubMed]
  • Conn HO. Endoscopic sclerotherapy: an analysis of variants. Hepatology. 1983 Sep-Oct;3(5):769–771. [PubMed]
  • Terblanche J, Bornman PC, Kirsch RE. Sclerotherapy for bleeding esophageal varices. Annu Rev Med. 1984;35:83–94. [PubMed]
  • Reynolds TB. What to do about esophageal varices? N Engl J Med. 1983 Dec 22;309(25):1575–1577. [PubMed]
  • Grace ND. Is sclerotherapy the treatment of choice for bleeding esophageal varices? Mayo Clin Proc. 1985 Mar;60(3):207–210. [PubMed]
  • Terblanche J. The long-term management of patients after an oesophageal variceal bleed: the role of sclerotherapy. Br J Surg. 1985 Feb;72(2):88–90. [PubMed]
  • Johnson WC, Widrich WC, Ansell JE, Robbins AH, Nabseth DC. Control of bleeding varices by vasopressin: a prospective randomized study. Ann Surg. 1977 Sep;186(3):369–376. [PubMed]
  • Freeman JG, Cobden I, Lishman AH, Record CO. Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices. Lancet. 1982 Jul 10;2(8289):66–68. [PubMed]
  • Jenkins SA, Baxter JN, Corbett W, Devitt P, Ware J, Shields R. A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J (Clin Res Ed) 1985 Jan 26;290(6464):275–278. [PMC free article] [PubMed]
  • NACHLAS MM. Experiences with the triple-lumen single-balloon tube in massive upper gastrointestinal hemorrhage. Gastroenterology. 1956 Jun;30(6):913–928. [PubMed]
  • CONN HO. Hazards attending the use of esophageal tamponade. N Engl J Med. 1958 Oct 9;259(15):701–707. [PubMed]
  • Johnston GW, Rodgers HW. A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices. Br J Surg. 1973 Oct;60(10):797–800. [PubMed]
  • Terblanche J, Yakoob HI, Bornman PC, Stiegmann GV, Bane R, Jonker M, Wright J, Kirsch R. Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy. Ann Surg. 1981 Oct;194(4):521–530. [PubMed]
  • Sarin SK, Sachdeva GK, Nanda R, Vij JC, Anand BS. Endoscopic sclerotherapy using absolute alcohol. Gut. 1985 Feb;26(2):120–124. [PMC free article] [PubMed]
  • Hine KR, Morris D, Toghill P, Dykes PW. Fluorescein mixed with sclerosant improves the accuracy of endoscopic injection of oesophageal varices. Lancet. 1984 Aug 11;2(8398):322–323. [PubMed]
  • Seidman E, Weber AM, Morin CL, Ethier R, Lamarche JB, Guerguérian AJ, Geoffroy G, Roy CC. Spinal cord paralysis following sclerotherapy for esophageal varices. Hepatology. 1984 Sep-Oct;4(5):950–954. [PubMed]
  • Lunderquist A, Vang J. Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med. 1974 Sep 26;291(13):646–649. [PubMed]
  • Bengmark S, Börjesson B, Hoevels J, Joelsson B, Lunderquist A, Owman T. Obliteration of esophageal varices by PTP: a follow-up of 43 patients. Ann Surg. 1979 Oct;190(4):549–554. [PubMed]
  • MacDougall BR, Westaby D, Theodossi A, Dawson JL, Williams R. Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet. 1982 Jan 16;1(8264):124–127. [PubMed]
  • Stamatakis JD, Howard ER, Psacharopoulos HT, Mowat AP. Injection sclerotherapy for oesophageal varices in children. Br J Surg. 1982 Feb;69(2):74–75. [PubMed]
  • Tyson KR, Schuster SR, Shwachman H. Portal hypertension in cystic fibrosis. J Pediatr Surg. 1968 Apr;3(2):271–277. [PubMed]
  • Schuster SR, Shwachman H, Toyama WM, Rubino A, Taik-Khaw K. The management of portal hypertension in cystic fibrosis. J Pediatr Surg. 1977 Apr;12(2):201–206. [PubMed]
  • Warren WD, Millikan WJ, Jr, Henderson JM, Wright L, Kutner M, Smith RB, 3rd, Fulenwider JT, Salam AA, Galambos JT. Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg. 1982 May;195(5):530–542. [PubMed]
  • Lebrec D, Poynard T, Hillon P, Benhamou JP. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med. 1981 Dec 3;305(23):1371–1374. [PubMed]
  • Burroughs AK, Jenkins WJ, Sherlock S, Dunk A, Walt RP, Osuafor TO, Mackie S, Dick R. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med. 1983 Dec 22;309(25):1539–1542. [PubMed]
  • Ozsoylu S, Koçak N, Yüce A. Propranolol therapy for portal hypertension in children. J Pediatr. 1985 Feb;106(2):317–321. [PubMed]
  • Resnick RH, Chalmers TC, Ishihara AM, Garceau AJ, Callow AD, Schimmel EM, O'Hara ET. A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med. 1969 Apr;70(4):675–688. [PubMed]
  • Cello JP, Grendell JH, Crass RA, Trunkey DD, Cobb EE, Heilbron DC. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med. 1984 Dec 20;311(25):1589–1594. [PubMed]
  • Richardson VF, Robertson CF, Mowat AP, Howard ER, Price JF. Deterioration in lung function after general anaesthesia in patients with cystic fibrosis. Acta Paediatr Scand. 1984 Jan;73(1):75–79. [PubMed]
  • Viallet A, Marleau D, Huet M, Martin F, Farley A, Villeneuve JP, Lavoie P. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology. 1975 Dec;69(6):1297–1300. [PubMed]
  • REYNOLDS TB, REDEKER AG, GELLER HM. Wedged hepatic venous pressure; a clinical evaluation. Am J Med. 1957 Mar;22(3):341–350. [PubMed]
  • Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980 Dec;79(6):1139–1144. [PubMed]
  • PALMER ED, BRICK IB. Correlation between the severity of esophageal varices in portal cirrhosis and their propensity toward hemorrhage. Gastroenterology. 1956 Jan;30(1):85–90. [PubMed]
  • Alvarez F, Bernard O, Brunelle F, Hadchouel P, Odièvre M, Alagille D. Portal obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediatr. 1983 Nov;103(5):696–702. [PubMed]
  • Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc. 1981 Nov;27(4):213–218. [PubMed]
  • McCormack T, Martin T, Smallwood RH, Robinson P, Walton L, Johnson AG. Doppler ultrasound probe for assessment of blood-flow in oesophageal varices. Lancet. 1983 Mar 26;1(8326 Pt 1):677–678. [PubMed]
  • Paquet KJ. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial. Endoscopy. 1982 Jan;14(1):4–5. [PubMed]
  • el-Khishen MA, Henderson JM, Millikan WJ, Jr, Kutner MH, Warren WD. Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension. Surg Gynecol Obstet. 1985 Mar;160(3):233–238. [PubMed]
  • Witte CL, Witte MH, Renert W, O'Mara RE, Lilien DL. Splenic artery ligation in selected patients with hepatic cirrhosis and in Sprague-Dawley rats. Surg Gynecol Obstet. 1976 Jan;142(1):1–12. [PubMed]
  • Mozes MF, Spigos DG, Pollak R, Abejo R, Pavel DG, Tan WS, Jonasson O. Partial splenic embolization, an alternative to splenectomy--results of a prospective, randomized study. Surgery. 1984 Oct;96(4):694–702. [PubMed]
  • Mazer M, Smith CW, Martin VN. Distal splenic artery embolization with a flow-directed balloon catheter. Radiology. 1985 Jan;154(1):245–245. [PubMed]
  • Donnison AB, Shwachman H, Gross RE. A review of 164 children with meconium ileus seen at the Children's Hospital Medical Center, Boston. Pediatrics. 1966 May;37(5):833–850. [PubMed]
  • HOLSCLAW DS, ECKSTEIN HB, NIXON HH. MECONIUM ILEUS. A 20-YEAR REVIEW OF 109 CASES. Am J Dis Child. 1965 Feb;109:101–113. [PubMed]
  • BERNSTEIN J, VAWTER G, HARRIS GB, YOUNG V, HILLMAN LS. The occurrence of intestinal atresia in newborns with meconium ileus. The pathogenesis of an acquired anomaly. AMA J Dis Child. 1960 Jun;99:804–818. [PubMed]
  • Hughes CA, Talbot IC, Ducker DA, Harran MJ. Total parenteral nutrition in infancy: effect on the liver and suggested pathogenesis. Gut. 1983 Mar;24(3):241–248. [PMC free article] [PubMed]
  • Cohen C, Olsen MM. Pediatric total parenteral nutrition. Liver histopathology. Arch Pathol Lab Med. 1981 Mar;105(3):152–156. [PubMed]
  • Corrigan JJ, Jr, Taussig LM, Beckerman R, Wagener JS. Factor II (prothrombin) coagulant activity in immunoreactive protein: detection of vitamin K deficiency and liver disease in patients with cystic fibrosis. J Pediatr. 1981 Aug;99(2):254–257. [PubMed]
  • Friedman HZ, Langman CB, Favus MJ. Vitamin D metabolism and osteomalacia in cystic fibrosis. Gastroenterology. 1985 Mar;88(3):808–813. [PubMed]
  • Larcher VF, Macdonald A, Vegnente A, Mowat AP, Eddleston AL, Williams R. Antibodies to liver-specific lipoprotein in children with chronic liver disease due to "autoimmune" chronic active hepatitis, cystic fibrosis, and alpha 1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr. 1984 Nov;3(5):728–733. [PubMed]
  • Arborgh B, Eklund A, Norman A, Strandvik B. Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis. Scand J Gastroenterol. 1980;15(1):73–80. [PubMed]
  • Strandvik B, Samuelson K. Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis. Scand J Gastroenterol. 1985 Apr;20(3):381–384. [PubMed]
  • Graham N, Manhire AR, Stead RJ, Lees WR, Hodson ME, Batten JC. Cystic fibrosis: ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology. Clin Radiol. 1985 Mar;36(2):199–203. [PubMed]
  • Wilson-Sharp RC, Irving HC, Brown RC, Chalmers DM, Littlewood JM. Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis. Arch Dis Child. 1984 Oct;59(10):923–926. [PMC free article] [PubMed]
  • Cunningham DG, Churchill RJ, Reynes CJ. Computed tomography in the evaluation of liver disease in cystic fibrosis patients. J Comput Assist Tomogr. 1980 Apr;4(2):151–154. [PubMed]
  • Clarke M, Tanner MS, Allen R, Milford-Ward A. Alpha1-antitrypsin deficiency and liver disease. Br Med J (Clin Res Ed) 1981 Nov 07;283(6301):a1263–1263. [PMC free article]
  • Mieli-Vergani G, Psacharopoulos HT, Nicholson AM, Eddleston AL, Mowat AP, Williams R. Immune responses to liver membrane antigens in patients with cystic fibrosis and liver disease. Arch Dis Child. 1980 Sep;55(9):696–701. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press